Donor chimerism and minimal residual disease monitoring in leukemia patients after allo-HSCT

   
Bogdanov K.V.1 , Motorin D.V.1, Nikulina T.S.1, Pisotskaya O.S.1, Babenetskaya D.V.1, Mirolyubova Y.V.1, Volkova O.Y.1, Zaritskiy A.Y.1

1. Institute of Hematology, Federal V.A. Almazov North-West Medical Research Centre, St. Petersburg, Russia
Section: Clinical and Diagnostic Research
DOI: 10.18097/PBMC20176306570      PubMed Id: 29251621
Year: 2017  Volume: 63  Issue: 6  Pages: 570-581
In present research the comparative analysis of donor chimerism (DC) using different tests was performed to improve the diagnostic tool in patients with malignant hematological disorders after allo-HSCT. The RBC antigen typing, identification of ABO blood type and quantitative analysis of InDel-, STR-, Y-polymorphisms were carried out for detection of DC. In addition, the expression of well-known oncogenes and CD-markers for monitoring MRD was evaluated to predict relapse and clinical outcome. According to our research, the analysis of InDel polymorphism using AlleleSEQR-PCR is more sensitive test for estimation of DC as compared with other assays. Moreover, the sensitivity of AlleleSEQR-PCR may be increased after isolation of the CD34 cell population in bone marrow. Nevertheless, observation of high levels in DC (³95%) in some leukemia patients (ALL, Ph+, bcr-abl/p190+) during first 6 months after HSCT cannot exclude the possibility of relapse. Thus, the combined monitoring of both DC (InDel) and MRD (oncogenes, WT1 and CD-markers) is a more advisable and useful test in managing hematologic malignancies and predicting relapse risk after allo-HSCT.
Download PDF:  
Keywords: leukemia, transplantation, monitoring, donor chimerism, MRD
Citation:

Bogdanov, K. V., Motorin, D. V., Nikulina, T. S., Pisotskaya, O. S., Babenetskaya, D. V., Mirolyubova, Y. V., Volkova, O. Y., Zaritskiy, A. Y. (2017). Donor chimerism and minimal residual disease monitoring in leukemia patients after allo-HSCT. Biomeditsinskaya Khimiya, 63(6), 570-581.
References  
 2024 (vol 70)
 2023 (vol 69)
 2022 (vol 68)
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)